2008 News |
 |
 |
INNOVATE-PCI enrolls first patient |
 |
Improved heart failure treatments don't improve long-term outcomes for patients |
 |
Combination therapy lowers cardiovascular risks for patients with high blood pressure |
 |
Patients with bleeding problems after heart attack less likely to have anti-blood clot therapy |
 |
Duke researchers propose operational improvements to modern clinical epidemiology |
 |
VADs are linked to high hospital costs, high death rates for Medicare patient |
 |
Rob Califf, ASCEND-HF trial highlighted in New York Times |
 |
Certain antidepressants don't increase risk of death for patients with heart failure |
 |
Heart failure patients exercise, improve quality of life |
 |
Half an hour of walking can lower risks for heart failure patients |
 |
DCRI researchers identify protein signature that may predict who responds to hepatitis C treatment |
 |
Several methods are effective for treating teens with anxiety disorder |
 |
Duke named one of three AHA Pharmaceutical Roundtable Outcomes Research Centers |
 |
DCRI research finds that vaccinating families of newborns help protect infants from the flu |
 |
DCRI's John Sundy leads research on possible new treatment for patients with gout |
 |
On a more level playing field, hospitals’ pay-for-performance rankings shift |
 |
Study finds link between depression and higher risk of death for patients on chronic dialysis |
 |
Testing changes in electrical activity in the heart immediately following PCI can better predict necessary care |
 |
Researchers identify genes that might indicate the extent of coronary artery disease in patients |
 |
VIGOUR hopes for more researchers in developing countries |
 |
Nursing intervention helps relieve depression in patients with heart failure |
 |
Study finds new anti-blood clot drug increases bleeding but lowers heart attack risk |
 |
Bacteria in the blood likely signals device infection in patients with pacemakers, defibrillators |
 |
Patients with heart failure face greater risk of death following ICD shocks |
 |
Defibrillators reduce risk of death without diminishing quality of life |
 |
Post-market monitoring crucial to detecting adverse side effects of drugs used in children |
 |
Low levels of “good” cholesterol may be a prognostic indicator and target for intervention |
 |
Some financial relationships don't impact patient enrollment in trials |
 |
Hospitals made improvements during CRUSADE but there is room for further improvements |
 |
Novel strategies needed to decrease mortality risk in elderly women with heart disease |
 |
DCRI researchers find safer way to insert coronary stents is rarely used |
 |
DCRI researchers find younger, white patients more likely to undergo cardiac resynchronization |
 |
DCRI researchers weigh benefits of smaller versus larger drug-safety databases |
 |
DCRI researchers propose framework for studying CV imaging technologies |
 |
Atrial fibrillation is associated with greater risk of death for acute coronary patients |
 |
Experts examine key issues related to post-market evaluation of medical devices |
 |
Smokers with coronary syndrome are younger, but don't have higher mortality rates |
 |
Community hospitals don't transfer many patients who need cardiac catheterization |
 |
ED-based research needed to improve quality and reduce disparities in emergency care |
 |
New study finds women with heart disease, diabetes have worse stroke outcomes |
 |
New guidelines recommend cholesterol screening for overweight kids |
 |
Informed consent essential to fostering trust in medical research |
 |
Trial indicates new anticoagulant and antidote could be safe, fast option for patients |
 |
Screening older patients for HIV can be a cost-effective health tool |
 |
Heart failure patients overestimate their life span |
 |
Despite treatment delays, off-hour heart attack patients don't have increased risk of death |
 |
Despite treatment delays, off-hour heart attack patients don't have increased risk of death |
 |
Research about coronary stents does not always disclose authors' financial stakes |
 |
New drug-eluting stents not any safer than traditional stents, according to a new study |
 |
JAMA editorial: Eric Peterson and Tracy Wang on preventive cardiology |
 |
Trial participants not overly concerned by researchers' financial interests in trials |
 |
Late-breaking clinical trial at ACC: Groundbreaking results from ACCOMPLISH |
 |
ACC presentation: Making progress including women in clinical trials |
 |
Late-breaking clinical trial at ACC: MEND-CABG II trial results |
 |
Late-breaking clinical trial at ACC: Home Automated External Defibrillator Trial results |
 |
ACC presentation: Warning signs of sudden cardiac death after heart attack |
 |
Late-breaking clinical trial at ACC: Angioplasty at medical centers without on-site cardiac surgery |
 |
Lack of NIH funding increases is straining younger researchers |
 |
Pessimistic heart patients have higher risk of death |
 |
Coronary bypass surgery effective but high-risk procedure for cardiogenic shock patients |
 |
More elderly Americans are living with heart failure |
 |
Acute hypertension patients don't receive enough follow-up |
 |
Drug used in cardiac surgery increases mortality rate, DCRI researchers confirm |
 |
Inaugural Class of Global Health Residency Program Announced |
 |
New drug could minimize damage from heart attack treatment |
 |
Blood clot treatment puts patients at greater risk of decreased level of platelets |
 |
DCRI researchers complete first study on anti-clotting drugs for children |
 |
Lower doses of aspirin are safer and as effective |
 |
Global blood transfusion patterns raise questions |
| |
|